Medically reviewed by Sanja Jelic, MD Asthma and chronic obstructive pulmonary disease (COPD) are chronic respiratory (lung) ...

This health education program aims to help patients living with COPD experience better health outcomes and improved quality ...

Biotech company Regeneron (REGN) and French pharmaceutical giant Sanofi (SNY) today announced that Japan has granted ...

Between the first week of pulmonary rehabilitation and the last recorded session before transplantation, lung transplant ...

This progressive lung disease transforms healthy tissue into stiff, scarred areas making breathing difficult. Learn the ...

Treatments for COPD can include lifestyle changes, oral and inhaled medicines, oxygen therapy, and surgery. Though there’s no cure for the condition, you can manage the symptoms. Follow your ...

Sanofi & Regeneron’s Dupixent receives Japanese marketing approval to treat patients with COPD: Paris Saturday, March 29, 2025, 09:00 Hrs [IST] The Ministry of Health, Labour an ...

Dupixent approved as the first-ever biologic medicine in Japan for patients with COPDFollowing recent approvals in the EU, China, and the US, ...

The European Medicines Agency will review GSK's request to approve its asthma drug Nucala as an additional treatment for ...

Researchers have found a potential new way to slow the progression of lung fibrosis and other fibrotic diseases by inhibiting ...

Emerging evidence shows glucose-lowering medications may have the potential to improve chronic obstructive pulmonary disease ...